Your browser doesn't support javascript.
Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis.
Shin, Robert K; Rammohan, Kottil W; Williams, Mitzi J.
  • Shin RK; MedStar Georgetown University Hospital, 3800 Reservoir Rd NW, Washington, DC, 20007, USA. Robert.K.Shin@gunet.georgetown.edu.
  • Rammohan KW; University of Miami Miller School of Medicine, Miami, FL, USA.
  • Williams MJ; Joi Life Wellness Group, Atlanta, GA, USA.
Neurol Ther ; 10(2): 415-425, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1340490
COVID-19 vaccines are safe for people living with MS on or off disease-modifying therapies and are important for the prevention of COVID-19. Antibody responses for individuals on certain DMTs may be diminished, however, T-cell responses may be preserved in those individuals. Data are lacking regarding optimal timing of vaccinations, and delaying disease-modifying therapies may increase the risk of disease activity and progression. In this perspective podcast, the authors recommend COVID-19 vaccination as soon as possible, regardless of timing considerations, in most cases.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines Language: English Journal: Neurol Ther Year: 2021 Document Type: Article Affiliation country: S40120-021-00266-z

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines Language: English Journal: Neurol Ther Year: 2021 Document Type: Article Affiliation country: S40120-021-00266-z